Mergers & Acquisitions
12-23-2008 |
12:19 hs.
12-18-2008 |
17:54 hs.
Wyeth said it had pay30 million to buy privately held biotechnology company Thiakis Ltd. The Madison, New Jersey-based company will make additional payments up to $120 million to private investors of Thiakis if its pipeline achieves certain development milestones and clinical objectives
.
.
12-17-2008 |
14:29 hs.
Chicago-based Abbott Laboratories announced a total payment of 175 million dollars to purchase the remaining equity to take over California based Ibis Biosciences Inc. a specialized company in medical diagnostic.
11-26-2008 |
16:56 hs.
King Pharmaceutical Inc said is exploring alternative financing structure for its $1.6 billion proposed acquisition of Alpharma Inc. Early this week, King agreed to acquire Alpharma, ending a takeover battle and expanding King´s presence into the pain market
$50 million deal
11-25-2008 |
07:58 hs.
Swiss drugmaker Roche Holding AG announced that signed a definitive merger agreement to acquire all the outstanding shares of Memory Pharmaceuticals Inc. in an all-cash transaction for some $50 million. Both companies are already in partnered programmes for disorders such as Alzheimer´s disease and schizophrenia.
11-24-2008 |
15:26 hs.
King Pharmaceuticals’ and Alpharma Inc’s boards signed an agreement in which the Bristol, Tennessee-based company will acquire Bridgewater, New Jersey-based for about $1.6 billion. The amount is the same that Alpharma had rejected as too low last month and ends a takeover fight that began with King’s $1.4 billion offer last August.
$70 per share
10-14-2008 |
12:04 hs.
Some stories behind the billion-dollar saga
10-07-2008 |
11:37 hs.
UBS AG bankers were behind Eli Lilly & Co striking the $ 6.5 billion-dollar deal to acquire ImClone Systems Inc, while their own research analyst was telling Eli Lilly it was paying too much.
10-06-2008 |
13:35 hs.
Bristol-Myers Squibb Co. will sell its 17 percent stake in ImClone Systems Inc., the biotechnology company that agreed today to be bought by Eli Lilly & Co. for $6.5 billion. However, Bristol will continue to co-market in the U.S. ImClone´s only product, the blockbuster drug Erbitux
Confidential agreement
10-06-2008 |
10:17 hs.
09-22-2008 |
08:35 hs.
Sanofi-Aventis said that it has agreed to buy Czech generic drug maker Zentiva for around $ 2.6 billion after raising its previous bid by almost 10 percent. However, the bid is conditional on gaining more than 50 percent of control over Zentiva, along with competition clearance.
09-16-2008 |
12:18 hs.
09-01-2008 |
11:08 hs.
08-21-2008 |
12:01 hs.
08-15-2008 |
11:50 hs.
Sweddish Meda AB has reached an agreement with the Swiss pharma company Roche Holding to acquire four of their pharmaceutical products. Further details.
07-09-2008 |
10:06 hs.
07-03-2008 |
15:02 hs.
Shire Plc, the U.K.´s third-biggest drugmaker, agreed to pay $520.7 million in cash for Germany´s Jerini AG to add Firazyr, a treatment for hereditary angioedema, a fatal and rare tissue swelling condition.
07-02-2008 |
16:41 hs.
For approximately $ 190 M
05-29-2008 |
12:21 hs.
Bristol-Myers Squibb Co announced signing an agreement with Kosan Biosciences Inc, a cancer therapeutics company, for an approximately $ 190 million dollars acquisition of the biotech firm, a transaction giving BMS two pipeline cancer treating drugs in the Hsp90 inhibitor and epothilone classes. Further details.
$ 360 Million Dollar Deal
03-31-2008 |
16:50 hs.
